tiprankstipranks

Frank Mccormick Insider Profile

4 Followers
Frank Mccormick, Director at BridgeBio Pharma, holds 767.24K shares in BridgeBio Pharma (Ticker: BBIO), holds 275.37K shares in Olema Pharmaceuticals (Ticker: OLMA), holds ― shares in BridgeBio Oncology Therapeutics (Ticker: BBOT).
tipranks
Frank Mccormick

Frank Mccormick
BridgeBio Pharma (BBIO)
Director

Ranked #79,759 out of 108,437 Corporate Insiders

Profitable Transactions

0%
0 out of 2 Profitable Transactions

Average Return

-30.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$68M
95.13%
4.87%
0.00%
0.00%
A breakdown of Frank Mccormick's holdings

Insider Roles

BridgeBio Pharma
(BBIO)
Director
Olema Pharmaceuticals
(OLMA)
Director
BridgeBio Oncology Therapeutics
(BBOT)
Director
Exelixis
(EXEL)
Director
Roles that Frank Mccormick holds in companies

Most Profitable Insider Trade

Stock:
BridgeBio Pharma
(BBIO)
Rating:Informative Sell
Date:Nov 17, 2020 - Nov 17, 2021
Return:-5.80%
The most profitable trade made by Frank Mccormick

Frank Mccormick's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
BridgeBio Pharma
Jun 24, 2026
Director
Uninformative Buy
$64.82M
Olema Pharmaceuticals
Nov 23, 2020
Director
Uninformative Buy
$3.32M
BridgeBio Oncology Therapeutics
Director
KDNY
Chinook Therapeutics
$0.00
Exelixis
Director
$0.00
List of latest transactions for each holding click on a transaction to see Frank Mccormick's performance on stock

Frank Mccormick insider profile FAQ

What is the percentage of profitable transactions made by Frank Mccormick?
The percentage of profitable transactions made by Frank Mccormick is 0%.
    What is the average return per transaction made by Frank Mccormick?
    The average return per transaction made by Frank Mccormick is -30.70%.
      What stocks does Frank Mccormick hold?
      Frank Mccormick holds: BBIO, OLMA, BBOT, KDNY, EXEL stocks.
        What was Frank Mccormick’s latest transaction?
        Frank Mccormick latest transaction was an Uninformative Buy of ―.
          What was Frank Mccormick's most profitable transaction?
          Frank Mccormick’s most profitable transaction was an Informative Sell of BBIO stock on November 17, 2020. The return on the trade was -5.80%.
            What is Frank Mccormick's role in BridgeBio Pharma?
            Frank Mccormick's role in BridgeBio Pharma is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.